Navigation Links
Lawson researcher sings the baby blues
Date:8/22/2012

LONDON, ON The impact of bipolar disorder during pregnancy has been hotly contended among the research community. Now, a new study from Lawson Health Research Institute and Western University is sorting out the debate and calling for more targeted, prospective research.

Bipolar disorder is characterized by depression, hypomania, or mania. It is most common among women, and its episodes are often concentrated during the height of the reproductive years.

Bipolar disorder can lead to suicide, infanticide, and increased risk for psychiatric hospitalization during the postpartum period. During pregnancy, though, the impact is unclear. Through a comprehensive literature review, Dr. Verinder Sharma and his team sought to clearly define what scientists already knew about bipolar disorder during pregnancy, and where they should look next.

Despite contradictory findings, their review suggests pregnancy could have a positive impact on bipolar disorder. Throughout the literature, bipolar II disorder was either uncommon or in remission during pregnancy. Women already diagnosed with bipolar disorder had fewer and shorter episodes while pregnant. Pregnant women also had a lower risk of any other mood disorder than non-pregnant women.

However, the impact of mood stabilizer medications has complicated much of the existing data. In the literature, bipolar disorder is often misdiagnosed as depression, and antidepressants are prescribed as treatment. These medications are known to make bipolar symptoms worse. Similarly, many women taking mood stabilizers discontinue their prescriptions to avoid potential side effects on their unborn babies. This rapid break appears to provoke bipolar episodes.

These circumstances have made it challenging for scientists to separate the impact of the drugs from the impact of the disorder. To make a clear judgment, Dr. Sharma is calling for large, multicenter, prospective studies that specifically address the natural course of the disorder.

"There is no period in a woman's life when the risk of relapse of bipolar disorder is as high as in the postpartum period. This is in sharp contrast to pregnancy, when women may experience an improvement in their symptoms," he says. "If we fail to understand the effect of pregnancy on bipolar disorder, we will fail to understand bipolar disorder."


'/>"/>
Contact: Sonya Gilpin
sonya.gilpin@lawsonresearch.com
519-685-8500 x75852
Lawson Health Research Institute
Source:Eurekalert

Related biology news :

1. Lawson recieves Grand Challenges Explorations grant for groundbreaking research
2. ORNL researchers improve soil carbon cycling models
3. Researchers identify key culprit causing muscle atrophy
4. Notre Dame researcher is shedding light on how jaws evolve
5. Researchers demonstrate control of devastating cassava virus in Africa
6. Rutgers-Camden genetics researcher receives NSF CAREER Award
7. WSU researcher sees how forests thrive after fires and volcanoes
8. Researchers pursue red flag for schizophrenia relapse
9. A new line of defense: Researchers find cattle vaccine works to reduce E. coli O157:H7
10. Queens researcher finds situation dire for threatened rhino species
11. Iowa State, Ames Lab researchers invent new tool to study single biological molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  GlobeImmune, Inc. today ... for the sale of 12,835,490 shares of its common ...  ecosystem of companies. In connection with the sale of its ... in cash and issue to GlobeImmune 200,000 shares, an ... "We are pleased to enter into ...
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research ... GSK to generate genetic sequence data from the 500,000 volunteer ... researchers to gain valuable insights to support advances in the ... and life threatening diseases. ... Genetic evidence has revolutionized scientific discovery ...
Breaking Biology Technology: